SCHEMBL1630451

SCHEMBL1630451

COc1cc(OC)c(-c2ccnn2-c2cccc(C)c2)cc1Sc1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C2 P08235 1/20 0.39
PDE10A Q9Y233 5/20 0.38
MAPK14 Q16539 2/20 0.38
ALDH1A1 P00352 3/20 0.37
HPGD P15428 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.36
KMT2A Q03164 1/20 0.36
PTGER1 P34995 1/20 0.36
NPBWR1 P48145 2/20 0.35
MCHR1 Q99705 2/20 0.35
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.34
ALOX15 P16050 1/20 0.34
MAPK1 P28482 1/20 0.34
HSD17B10 Q99714 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
UGCG Q16739 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1629193 0.81 NR3C2 (0.43) NR3C2MAPK14ALDH1A1KMT2APTGER1
SCHEMBL1628962 0.80 MAPK14 (0.42) NR3C2PDE10AMAPK14ALDH1A1HPGD
SCHEMBL1631632 0.80 HSP90AA1 (0.39) NR3C2PDE10AMAPK14ALDH1A1HPGD
SCHEMBL12722869 0.73 PDE10A (0.49) NR3C2PDE10AALDH1A1LMNAGAA
SCHEMBL1629555 0.72 PDE10A (0.48) PDE10AALDH1A1KDM4EMEN1LMNA
SCHEMBL1629120 0.72 HSP90AA1 (0.47) NR3C2PDE10AMAPK14GAAMAPT
SCHEMBL1628842 0.71 MAPT (0.44) PDE10AALDH1A1HPGDKDM4EMEN1
SCHEMBL10258287 0.70 ALDH1A1 (0.55) PDE10AMAPK14ALDH1A1HPGDKDM4E
SCHEMBL12722811 0.69 PDE10A (0.48) PDE10AALDH1A1HPGDKDM4ELMNA
SCHEMBL12722862 0.68 HSP90AA1 (0.47) PDE10AALDH1A1PTGER1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P NR3C2 558/4885PDE10A 3756/4885MAPK14 1929/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.